The prominent variants in Japanese ccRCC were VHL, PBRM1, BAP1, and SETD2, as well as chr.3p loss and chr.5q gain, similar to previous large studies, including the TCGA study7,15,16,25,48. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.